Chemistry Reference
In-Depth Information
[42] Levitsky, K., Ciolli, C. J. and Belshaw, P. J. (2003). Selective inhibition of engineered receptors
via proximity-accelerated alkylation.
Org. Lett
.
5
, 693-696.
[43] Chen, G., Heim, A., Riether, D., Yee, D., Milgrom, Y., Gawinowicz, M. A. and Sames, D.
(2003). Reactivity of functional groups on the protein surface: development of epoxide probes
for protein labeling.
J. Am. Chem. Soc
.
125
, 8130-8133.
[44] Johnson, J. L., Cusack, B., Hughes, T. F., McCullough, E. H., Fauq,A., Romanovskis, P., Spatola,
A. F. and Rosenberry, T. L. (2003). Inhibitors tethered near the acetylcholinesterase active site
serve as molecular rulers of the peripheral and acylation sites.
J. Biol. Chem
.
278
, 38948-38955.
[45] Hansen, S. K., Cancilla, M. T., Shiau, T. P., Kung, J., Chen, T. and Erlanson, D. A. (2005).
Allosteric inhibition of PTP1B activity by selective modification of a non-active site cysteine
residue.
Biochemistry
44
, 7704-7712.
[46] Lewis, W. G., Green, L. G., Grynszpan, F., Radic, Z., Carlier, P. R., Taylor, P., Finn, M. G. and
Sharpless, K. B. (2002). Click chemistry
in situ
: acetylcholinesterase as a reaction vessel for the
selective assembly of a femtomolar inhibitor from an array of building blocks.
Angew. Chem.
Int. Ed
.
41
, 1053-1057.
[47] Kolb, H. C. and Sharpless, K. B. (2003). The growing impact of click chemistry on drug
discovery.
Drug Discov. Today
8
, 1128-1137.
[48] Baskin, J. M., Prescher, J. A., Laughlin, S. T., Agard, N. J., Chang, P. V., Miller, I. A., Lo, A.,
Codelli, J. A. and Bertozzi, C. R. (2007). Copper-free click chemistry for dynamic
in vivo
imaging.
Proc. Natl. Acad. Sci. USA
104
, 16793-16797.
[49] Muir, T. (2003). Semisynthesis of proteins by expressed protein ligation.
Annu. Rev. Biochem
.
72
, 249-289.
[50] Cook, B. N. and Bertozzi, C. R. (2002). Chemical approaches to the investigation of cellular
systems.
Bioorg. Med. Chem
.
10
, 829-840.
[51] Jeffery, D. A. and Bogyo, M. (2003). Chemical proteomics and its application to drug discovery.
Curr. Opin. Biotechnol
.
14
, 87-95.
[52] Adam, G. C., Sorensen, E. J. and Cravatt, B. F. (2002). Chemical strategies for functional
proteomics.
Mol. Cell. Proteomics
1
, 781-790.
[53] Perret, P., Laube, B., Schemm, R., Betz, H., Goeldner, M. and Foucaud, B. (2002). Affinity
labeling of cysteine-mutants evidences contact residues in modeled receptor binding sites.
J.
Recept. Signal Transduct. Res
.
22
, 345-356.
[54] Li, W., Blankman, J. L. and Cravatt, B. F. (2007). A functional proteomic strategy to discover
inhibitors for uncharacterized hydrolases.
J. Am. Chem. Soc
.
129
, 9594-9595.
[55] Bohacek, R. S., McMartin, C. and Guida, W. C. (1996). The art and practice of structure-based
drug design: a molecular modeling perspective.
Med. Res. Rev
.
16
, 3-50.
